Less than two months after closing a $100m series C round, the Durham spinout has raised $225m in a series D led by SoftBank Vision Fund 2.

Exscientia, a UK-based drug discovery technology spinout of University of Dundee, secured $225m in series D financing yesterday led by SoftBank Vision Fund 2, a vehicle for telecoms conglomerate SoftBank. Pharmaceutical firms Novo and Bristol Myers Squibb also took part in the round, as did funds managed by BlackRock, GT Healthcare Capital, Marshall Wace, Pivotal…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.